| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 工艺研究与开发(元) | 28,584,452.29 | 48,160,997.27 | 21,965,693.22 | 77,868,176.89 | 41,057,123.95 |
| 商业化生产(元) | 123,461,379.48 | 165,214,033.62 | 79,196,377.63 | 109,401,023.32 | 45,961,516.31 |
| 药物发现(元) | 185,783,780.72 | 316,571,851.12 | 158,235,327.69 | 293,209,093.03 | 137,895,540.55 |
| 药学研究(元) | - | - | - | - | 4,202,266.79 |
| 营业成本(元) | |||||
| 工艺研究与开发(元) | 26,770,532.76 | 49,153,903.95 | 20,367,456.24 | 54,363,713.94 | 23,458,390.43 |
| 商业化生产(元) | 107,527,911.76 | 152,576,084.03 | 76,451,558.83 | 92,086,218.57 | 34,001,187.97 |
| 药物发现(元) | 119,626,227.22 | 212,801,042.62 | 105,747,505.12 | 192,064,694.90 | 88,917,801.75 |
| 药学研究(元) | - | - | - | - | 2,959,561.19 |
| 毛利(元) | |||||
| 工艺研究与开发(元) | 1,813,919.53 | -992,906.68 | 1,598,236.98 | 23,504,462.95 | 17,598,733.52 |
| 商业化生产(元) | 15,933,467.72 | 12,637,949.59 | 2,744,818.80 | 17,314,804.75 | 11,960,328.34 |
| 药物发现(元) | 66,157,553.50 | 103,770,808.50 | 52,487,822.57 | 101,144,398.13 | 48,977,738.80 |
| 药学研究(元) | - | - | - | - | 1,242,705.60 |
| 毛利率(%) | |||||
| 工艺研究与开发(%) | 6.35 | -2.06 | 7.28 | 30.18 | 42.86 |
| 商业化生产(%) | 12.91 | 7.65 | 3.47 | 15.83 | 26.02 |
| 药物发现(%) | 35.61 | 32.78 | 33.17 | 34.50 | 35.52 |
| 药学研究(%) | - | - | - | - | 29.57 |
| 收入构成(%) | |||||
| 工艺研究与开发(%) | 8.46 | 9.09 | 8.47 | 16.21 | 17.92 |
| 商业化生产(%) | 36.55 | 31.18 | 30.53 | 22.77 | 20.06 |
| 药物发现(%) | 54.99 | 59.74 | 61.00 | 61.02 | 60.19 |
| 药学研究(%) | - | - | - | - | 1.83 |
| 毛利构成(%) | |||||
| 工艺研究与开发(%) | 2.16 | -0.86 | 2.81 | 16.56 | 22.06 |
| 商业化生产(%) | 18.99 | 10.95 | 4.83 | 12.20 | 14.99 |
| 药物发现(%) | 78.85 | 89.91 | 92.36 | 71.25 | 61.39 |
| 药学研究(%) | - | - | - | - | 1.56 |
